Advancing the Pharmaceutical Potential of Bioinorganic Hybrid Lipid‐Based Assemblies
Source abstract
Abstract
Abstract Bioinspired lipid assemblies that mimic the elaborate architecture of natural membranes have fascinated researchers for a long time. These lipid assemblies have gone from being just an imperative platform for biophysical research to a pharmaceutical delivery system for biomedical applications. Despite success, these organized nanosystems are often subject to the mechanical instability and limited theranostic capability without adding any inconvenient modifications. To reach their advanced pharmaceutical potential, various bioinorganic hybrid lipid‐based assembles, which provide new opportunities to synergistically complement and improve therapeutic/diagnostic potential of existing lipid‐based nanomedicine with distinct mechanisms containing inorganic embedded surfactants, have recently been developed.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Metal-Organic Frameworks: Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine School of Public Health Xiamen University Xiamen 361102 China
Center for Nanomedicine and Department of Anesthesiology Brigham and Women's Hospital Harvard Medical School Boston MA 02115 USA
Blood Cancer Cytogenetics and Genomics Laboratory Department of Anatomical and Cellular Pathology Prince of Wales Hospital The Chinese University of Hong Kong Shatin Hong Kong S.A.R. China
State Key Laboratory of Cellular Stress Biology Innovation Center for Cell Biology School of Life Sciences Xiamen University Xiamen 361102 China
The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation College of Chemistry and Chemical Engineering Xiamen University Xiamen 361005 China
Funding
National Natural Science Foundation of China · Program for New Century Excellent Talents in University
References (100+)
Show source-provided references
1. 10.3390/pharmaceutics902001210.3390/pharmaceutics9020012 ↗
2. Chang H. I. · Int. J. Nanomed. · 2012 · 7 · 49
3. 10.1101/cshperspect.a00469710.1101/cshperspect.a004697 ↗
4. 10.1039/c3cp50620g10.1039/c3cp50620g ↗
5. 10.1016/j.chemphyslip.2013.10.01110.1016/j.chemphyslip.2013.10.011 ↗
6. 10.1002/adma.20030001010.1002/adma.200300010 ↗
7. 10.1166/jbn.2017.242810.1166/jbn.2017.2428 ↗
8. 10.1166/jbn.2016.219410.1166/jbn.2016.2194 ↗
9. 10.1002/adma.20170535010.1002/adma.201705350 ↗
10. 10.1073/pnas.150579911210.1073/pnas.1505799112 ↗
11. 10.1016/j.scib.2018.05.00110.1016/j.scib.2018.05.001 ↗
12. 10.1016/0014-5793(81)80071-310.1016/0014-5793(81)80071-3 ↗
13. 10.1016/j.pnmrs.2013.01.00110.1016/j.pnmrs.2013.01.001 ↗
14. 10.1016/j.cocis.2005.09.00410.1016/j.cocis.2005.09.004 ↗
15. 10.1166/jbn.2016.228610.1166/jbn.2016.2286 ↗
16. 10.1021/acs.chemrev.5b0034410.1021/acs.chemrev.5b00344 ↗
17. 10.1038/nrd163210.1038/nrd1632 ↗
18. 10.1016/j.addr.2016.01.00810.1016/j.addr.2016.01.008 ↗
19. 10.1016/0024-3205(82)90455-610.1016/0024-3205(82)90455-6 ↗
20. 10.1016/S0378-5173(97)00135-X10.1016/S0378-5173(97)00135-X ↗
21. 10.1021/ja070748i10.1021/ja070748i ↗
22. 10.3389/fphar.2015.0028610.3389/fphar.2015.00286 ↗
23. 10.2217/17435889.1.3.29710.2217/17435889.1.3.297 ↗
24. 10.3797/scipharm.1208-0210.3797/scipharm.1208-02 ↗
25. 10.1517/1742524090296760710.1517/17425240902967607 ↗
26. 10.1021/nl052455y10.1021/nl052455y ↗
27. 10.1039/C8BM00003D10.1039/C8BM00003D ↗
28. 10.1016/j.biomaterials.2018.05.03610.1016/j.biomaterials.2018.05.036 ↗
29. 10.1002/smll.20160289610.1002/smll.201602896 ↗
30. Lin G. · Adv. Sci. · 2016 · 3 · 201600134
31. 10.1021/acsnano.8b0051610.1021/acsnano.8b00516 ↗
32. 10.1002/adma.20160327610.1002/adma.201603276 ↗
33. 10.1016/j.jallcom.2018.03.13310.1016/j.jallcom.2018.03.133 ↗
34. 10.1021/acsami.6b1157910.1021/acsami.6b11579 ↗
35. 10.1038/nnano.2009.45310.1038/nnano.2009.453 ↗
36. 10.21127/yaoyigc2017001310.21127/yaoyigc20170013 ↗
37. 10.1021/la025772i10.1021/la025772i ↗
38. 10.1021/acs.bioconjchem.7b0040710.1021/acs.bioconjchem.7b00407 ↗
39. 10.1021/acs.bioconjchem.6b0050810.1021/acs.bioconjchem.6b00508 ↗
40. 10.1021/ja304615y10.1021/ja304615y ↗
41. 10.1002/ejic.20120057910.1002/ejic.201200579 ↗
42. 10.1021/la903692510.1021/la9036925 ↗
43. 10.1038/am.2012.3010.1038/am.2012.30 ↗
44. 10.1246/bcsj.2017015610.1246/bcsj.20170156 ↗
45. Stamm M. · 2011
46. 10.1088/0957-4484/17/4/00610.1088/0957-4484/17/4/006 ↗
47. 10.1039/b822172c10.1039/b822172c ↗
48. 10.1038/nprot.2006.18210.1038/nprot.2006.182 ↗
49. 10.1039/c1cc10254k10.1039/c1cc10254k ↗
50. 10.1246/cl.1999.66110.1246/cl.1999.661 ↗
51. 10.1016/j.cis.2013.11.01410.1016/j.cis.2013.11.014 ↗
52. Kikuchi J.‐I. · 2011
53. 10.1002/chem.20070017510.1002/chem.200700175 ↗
54. 10.1023/A:102078140099810.1023/A:1020781400998 ↗
55. 10.1016/j.actbio.2012.05.02210.1016/j.actbio.2012.05.022 ↗
56. 10.1039/b926367e10.1039/b926367e ↗
57. 10.1039/C4RA08515A10.1039/C4RA08515A ↗
58. 10.1016/j.biomaterials.2011.08.04310.1016/j.biomaterials.2011.08.043 ↗
59. Fariss M. W. · Cancer Res. · 1994 · 54 · 3346
60. 10.1002/anie.20110355710.1002/anie.201103557 ↗
61. 10.1016/S0040-6090(03)00745-410.1016/S0040-6090(03)00745-4 ↗
62. 10.1002/chem.20130251810.1002/chem.201302518 ↗
63. 10.1016/j.colsurfb.2016.09.03310.1016/j.colsurfb.2016.09.033 ↗
64. 10.1021/ja025928110.1021/ja0259281 ↗
65. 10.1021/cr300061w10.1021/cr300061w ↗
66. 10.1002/smll.20110154510.1002/smll.201101545 ↗
67. 10.1016/j.biochi.2009.02.00310.1016/j.biochi.2009.02.003 ↗
68. 10.1021/acs.chemrev.6b0069010.1021/acs.chemrev.6b00690 ↗
69. 10.1007/978-1-4939-6591-5_2210.1007/978-1-4939-6591-5_22 ↗
70. 10.1016/j.bbamem.2004.06.00510.1016/j.bbamem.2004.06.005 ↗
71. 10.1246/cl.2012.122310.1246/cl.2012.1223 ↗
72. 10.1016/j.addr.2010.07.00910.1016/j.addr.2010.07.009 ↗
73. 10.1039/C7CP02908J10.1039/C7CP02908J ↗
74. 10.1039/C7CC04945E10.1039/C7CC04945E ↗
75. 10.1021/acs.organomet.5b0091710.1021/acs.organomet.5b00917 ↗
76. 10.1039/c3tb20807a10.1039/c3tb20807a ↗
77. 10.1039/c0cc05746k10.1039/c0cc05746k ↗
78. 10.7150/thno.2131710.7150/thno.21317 ↗
79. 10.3109/1354750X.2012.71567210.3109/1354750X.2012.715672 ↗
80. 10.1021/nn507482w10.1021/nn507482w ↗
81. Needham D. · Cancer Res. · 2000 · 60 · 1197
82. 10.1039/C6RA18112K10.1039/C6RA18112K ↗
83. 10.1021/la902459f10.1021/la902459f ↗
84. 10.1155/2013/13569810.1155/2013/135698 ↗
85. 10.1039/C5TB01197C10.1039/C5TB01197C ↗
86. 10.1016/S1470-2045(15)00039-X10.1016/S1470-2045(15)00039-X ↗
87. 10.1016/j.colsurfb.2014.06.01110.1016/j.colsurfb.2014.06.011 ↗
88. 10.1021/acsomega.6b0023210.1021/acsomega.6b00232 ↗
89. 10.1021/la401965a10.1021/la401965a ↗
90. 10.1002/adfm.20120166310.1002/adfm.201201663 ↗
91. 10.2147/IJN.S6691910.2147/IJN.S66919 ↗
92. 10.1021/acsami.5b0785610.1021/acsami.5b07856 ↗
93. 10.1021/bc500414e10.1021/bc500414e ↗
94. 10.1021/acsami.5b0366810.1021/acsami.5b03668 ↗
95. 10.1016/j.canlet.2017.11.01910.1016/j.canlet.2017.11.019 ↗
96. 10.1021/ar800223c10.1021/ar800223c ↗
97. 10.1016/S0020-1693(99)00467-310.1016/S0020-1693(99)00467-3 ↗
98. 10.1039/C3BM60235D10.1039/C3BM60235D ↗
99. 10.1021/la504496910.1021/la5044969 ↗
100. 10.1039/C4CS00293H10.1039/C4CS00293H ↗